chr12-68686948-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000502102.2(NUP107-DT):n.808A>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.333 in 1,195,324 control chromosomes in the GnomAD database, including 67,189 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.34 ( 8764 hom., cov: 34)
Exomes 𝑓: 0.33 ( 58425 hom. )
Consequence
NUP107-DT
ENST00000502102.2 non_coding_transcript_exon
ENST00000502102.2 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.124
Genes affected
NUP107 (HGNC:29914): (nucleoporin 107) This gene encodes a member of the nucleoporin family. The protein is localized to the nuclear rim and is an essential component of the nuclear pore complex (NPC). All molecules entering or leaving the nucleus either diffuse through or are actively transported by the NPC. Alternate transcriptional splice variants of this gene have been observed but have not been thoroughly characterized. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 12-68686948-T-G is Benign according to our data. Variant chr12-68686948-T-G is described in ClinVar as [Benign]. Clinvar id is 1269166.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.338 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
use as main transcript | n.68686948T>G | intergenic_region | ||||||
NUP107 | NM_020401.4 | c.-118T>G | upstream_gene_variant | ENST00000229179.9 | NP_065134.1 | |||
NUP107 | NM_001330192.2 | c.-233T>G | upstream_gene_variant | NP_001317121.1 | ||||
NUP107 | XM_005269037.5 | c.-118T>G | upstream_gene_variant | XP_005269094.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NUP107 | ENST00000229179.9 | c.-118T>G | upstream_gene_variant | 1 | NM_020401.4 | ENSP00000229179.4 |
Frequencies
GnomAD3 genomes AF: 0.338 AC: 51377AN: 152036Hom.: 8758 Cov.: 34
GnomAD3 genomes
AF:
AC:
51377
AN:
152036
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.332 AC: 346360AN: 1043170Hom.: 58425 Cov.: 13 AF XY: 0.331 AC XY: 176866AN XY: 534676
GnomAD4 exome
AF:
AC:
346360
AN:
1043170
Hom.:
Cov.:
13
AF XY:
AC XY:
176866
AN XY:
534676
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.338 AC: 51418AN: 152154Hom.: 8764 Cov.: 34 AF XY: 0.342 AC XY: 25441AN XY: 74400
GnomAD4 genome
AF:
AC:
51418
AN:
152154
Hom.:
Cov.:
34
AF XY:
AC XY:
25441
AN XY:
74400
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1150
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 20, 2019 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jul 15, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 44% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 41. Only high quality variants are reported. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at